SEC Comment Letter for Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — May 2, 2005
Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: May 2, 2005 · CIK: 0000715446 · Accession: 0000000000-05-021235
AI Filing Summary & Sentiment
Letter
Mail Stop 4-06 May 2, 2005 Henry P. Herms Director, Chief Financial Officer and Vice President - Finance CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747
RE: CopyTele, Inc. (file no. 033-86352) Form 10-K: for the Year Ended October 31, 2004 Form 10-K/A: for the Year Ended October 31, 2004 Form 10-Q: For the Quarterly Period Ended January 31,
Dear Mr. Herms,
We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments.
Very truly yours,
Craig Wilson
Senior Assistant Chief
Accountant
??
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Mail Stop 4-06 May 2, 2005 Henry P. Herms Director, Chief Financial Officer and Vice President - Finance CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747 RE: CopyTele, Inc. (file no. 033-86352) Form 10-K: for the Year Ended October 31, 2004 Form 10-K/A: for the Year Ended October 31, 2004 Form 10-Q: For the Quarterly Period Ended January 31, 2005 Dear Mr. Herms, We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. Very truly yours, Craig Wilson Senior Assistant Chief Accountant ?? ?? ?? ?? CopyTele, Inc. April 28, 2005 Page 1 of 1 </TEXT> </DOCUMENT>